- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 401/06 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Patent holdings for IPC class C07D 401/06
Total number of patents in this class: 4738
10-year publication summary
|
409
|
395
|
311
|
344
|
400
|
340
|
305
|
270
|
280
|
67
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Janssen Pharmaceutica N.V. | 3839 |
114 |
| Takeda Pharmaceutical Company Limited | 2961 |
101 |
| F. Hoffmann-La Roche AG | 7958 |
81 |
| Bristol-myers Squibb Company | 5080 |
79 |
| Merck Sharp & Dohme LLC | 3689 |
79 |
| Boehringer Ingelheim International GmbH | 4629 |
76 |
| Novartis AG | 11238 |
60 |
| VALO Health, Inc. | 147 |
53 |
| Merck Patent GmbH | 5909 |
46 |
| AstraZeneca AB | 3042 |
42 |
| Allergan, Inc. | 2600 |
38 |
| Astellas Pharma Inc. | 1145 |
37 |
| Eli Lilly and Company | 3645 |
36 |
| The Regents of the University of California | 18943 |
34 |
| Hoffmann-La Roche Inc. | 3060 |
33 |
| Mycovia Pharmaceuticals, Inc. | 40 |
33 |
| Centre National de La Recherche Scientifique | 9632 |
32 |
| ChemoCentryx, Inc. | 400 |
32 |
| Toray Industries, Inc. | 6652 |
31 |
| BASF SE | 19740 |
25 |
| Other owners | 3676 |